TRIM60
gene geneOn this page
Also known as FLJ35882
Summary
TRIM60 (tripartite motif containing 60, HGNC:21162) is a protein-coding gene on chromosome 4q32.3, encoding Tripartite motif-containing protein 60 (Q495X7). E3 SUMO-protein ligase that mediates SUMOylation of TAB2 leading to inhibition of NF-kappa-B and MAPK pathways by suppressing the TRAF6/TAB2/TAK1 complex.
The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. Pseudogenes of this gene are located on more than six chromosomes including chromosome 4. Multiple alternatively spliced variants, encoding the same protein, have been identified.
Source: NCBI Gene 166655 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_152620
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21162 |
| Approved symbol | TRIM60 |
| Name | tripartite motif containing 60 |
| Location | 4q32.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35882 |
| Ensembl gene | ENSG00000176979 |
| Ensembl biotype | protein_coding |
| OMIM | 619416 |
| Entrez | 166655 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000341062, ENST00000507119, ENST00000508504, ENST00000512596, ENST00000647760
RefSeq mRNA: 2 — MANE Select: NM_152620
NM_001258025, NM_152620
CCDS: CCDS3808
Canonical transcript exons
ENST00000512596 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002055276 | 165039201 | 165039252 |
| ENSE00002076607 | 165031999 | 165032112 |
| ENSE00003848655 | 165040069 | 165041749 |
Expression profiles
Bgee: expression breadth tissue_specific, 9 present calls, max score 86.09.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0589 / max 25.7703, expressed in 10 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 50430 | 0.0274 | 6 |
| 50431 | 0.0200 | 6 |
| 50429 | 0.0115 | 7 |
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.90 | gold quality |
| placenta | UBERON:0001987 | 68.45 | gold quality |
| testis | UBERON:0000473 | 51.18 | gold quality |
| right testis | UBERON:0004534 | 50.88 | gold quality |
| left testis | UBERON:0004533 | 49.75 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| apex of heart | UBERON:0002098 | 35.04 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| right uterine tube | UBERON:0001302 | 32.78 | gold quality |
| mucosa of stomach | UBERON:0001199 | 32.62 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| monocyte | CL:0000576 | 30.87 | silver quality |
| leukocyte | CL:0000738 | 30.57 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.21 | gold quality |
| liver | UBERON:0002107 | 28.76 | gold quality |
| tonsil | UBERON:0002372 | 28.67 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.41 | gold quality |
| calcaneal tendon | UBERON:0003701 | 26.65 | gold quality |
| right coronary artery | UBERON:0001625 | 26.56 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.23 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting TRIM60, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-802 | 99.61 | 67.70 | 1254 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-376A-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-376B-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-29B-1-5P | 98.86 | 68.35 | 1364 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-4520-3P | 98.75 | 66.55 | 963 |
| HSA-MIR-6804-3P | 98.72 | 64.82 | 852 |
| HSA-MIR-198 | 98.70 | 67.32 | 920 |
| HSA-MIR-892B | 98.00 | 67.11 | 821 |
| HSA-MIR-6501-5P | 97.41 | 68.24 | 712 |
| HSA-MIR-4794 | 96.47 | 65.53 | 1063 |
| HSA-MIR-664A-5P | 95.84 | 64.93 | 949 |
| HSA-MIR-4431 | 90.07 | 69.53 | 39 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Trim60 | ENSMUSG00000053490 |
Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890)
Protein
Protein identifiers
Tripartite motif-containing protein 60 — Q495X7 (reviewed: Q495X7)
Alternative names: RING finger protein 129, RING finger protein 33
All UniProt accessions (2): D6RAS2, Q495X7
UniProt curated annotations — full annotation on UniProt →
Function. E3 SUMO-protein ligase that mediates SUMOylation of TAB2 leading to inhibition of NF-kappa-B and MAPK pathways by suppressing the TRAF6/TAB2/TAK1 complex.
Similarity. Belongs to the TRIM/RBCC family.
RefSeq proteins (2): NP_001244954, NP_689833* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000315 | Znf_B-box | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR001870 | B30.2/SPRY | Domain |
| IPR003877 | SPRY_dom | Domain |
| IPR003879 | Butyrophylin_SPRY | Domain |
| IPR006574 | PRY | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR035786 | SPRY/PRY_TRIM60 | Domain |
| IPR043136 | B30.2/SPRY_sf | Homologous_superfamily |
| IPR050143 | TRIM/RBCC | Family |
Pfam: PF00622, PF00643, PF13765, PF15227
UniProt features (10 total): binding site 4, zinc finger region 2, chain 1, domain 1, coiled-coil region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q495X7-F1 | 86.05 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 97; 100; 119; 125
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 31 (showing top):
chr4q32, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_SUMO_TRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOMF_SUMO_LIGASE_ACTIVITY, HMGA1_TARGET_GENES, MIR5582_3P, MIR9902, MIR376A_3P_MIR376B_3P
GO Biological Process (6): regulation of gene expression (GO:0010468), innate immune response (GO:0045087), negative regulation of non-canonical NF-kappaB signal transduction (GO:1901223), canonical NF-kappaB signal transduction (GO:0007249), non-canonical NF-kappaB signal transduction (GO:0038061), protein K63-linked ubiquitination (GO:0070534)
GO Molecular Function (5): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), SUMO-ubiquitin ligase activity (GO:0140082), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular signaling cassette | 2 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| non-canonical NF-kappaB signal transduction | 1 |
| regulation of non-canonical NF-kappaB signal transduction | 1 |
| negative regulation of intracellular signal transduction | 1 |
| protein polyubiquitination | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| SUMO ligase activity | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
332 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRIM60 | KIF3B | O15066 | 777 |
| TRIM60 | KIF3A | Q9Y496 | 596 |
| TRIM60 | ZNF736 | B4DX44 | 594 |
| TRIM60 | ZNF679 | Q8IYX0 | 499 |
| TRIM60 | OR52E4 | Q8NGH9 | 463 |
| TRIM60 | BBOX1 | O75936 | 456 |
| TRIM60 | FAM218A | Q96MZ4 | 446 |
| TRIM60 | CALU | O43852 | 431 |
| TRIM60 | TRIM42 | Q8IWZ5 | 418 |
| TRIM60 | ZNF680 | Q8NEM1 | 412 |
| TRIM60 | SPIDR | Q14159 | 407 |
| TRIM60 | TRAT1 | Q6PIZ9 | 391 |
| TRIM60 | HGSNAT | Q68CP4 | 387 |
| TRIM60 | FNTA | P49354 | 386 |
| TRIM60 | HOOK3 | Q86VS8 | 381 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM60 | LNX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM60 | LNX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): TRIM60 (Affinity Capture-MS), TRIM60 (Two-hybrid), TRIM60 (Reconstituted Complex)
ESM2 similar proteins: A6NK02, A6NLU0, D4ABM4, F8VTS6, O00635, O19085, O77666, P14373, P15533, P62603, P86448, P86449, Q12899, Q2T9Z0, Q3UWZ0, Q495X7, Q58DK8, Q5BK82, Q5D7H7, Q5D7I6, Q5E9G4, Q5RBG2, Q5SZ99, Q5TM55, Q62158, Q62191, Q640S6, Q6AZZ1, Q6PGR9, Q7TPM3, Q7YR32, Q7YR33, Q7YR34, Q7YRV4, Q80X56, Q86WT6, Q8BVP1, Q8K243, Q8N7C3, Q8N9V2
Diamond homologs: A0JN74, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NK02, A6NLI5, B1H278, C9J1S8, K7N6K2, O00635, O15553, O19085, O77666, P0CI25, P0CI26, P14373, P15533, P18892, P19474, Q02084, Q0PF16, Q12899, Q13410, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q1XHU0, Q2T9Z0, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3UWZ0, Q3ZEE5, Q495X7, Q587N6, Q587N7, Q58DK8
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | TRIM60 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
342 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:165032111:AGG:A | donor_loss | 1.0000 |
| 4:165032112:GGTA:G | donor_loss | 1.0000 |
| 4:165032113:G:GG | donor_gain | 0.9900 |
| 4:165032114:T:G | donor_loss | 0.9900 |
| 4:165039232:G:GA | donor_gain | 0.9900 |
| 4:165040067:A:AG | acceptor_gain | 0.9900 |
| 4:165040068:G:GG | acceptor_gain | 0.9900 |
| 4:165040068:GCTC:G | acceptor_gain | 0.9900 |
| 4:165040067:AGCTC:A | acceptor_gain | 0.9800 |
| 4:165040068:GCTCG:G | acceptor_gain | 0.9800 |
| 4:165039231:T:TA | donor_gain | 0.9700 |
| 4:165040063:TCGCA:T | acceptor_loss | 0.9700 |
| 4:165040064:CGCA:C | acceptor_loss | 0.9700 |
| 4:165040065:GCA:G | acceptor_loss | 0.9700 |
| 4:165040066:CA:C | acceptor_loss | 0.9700 |
| 4:165040067:A:AT | acceptor_loss | 0.9700 |
| 4:165039233:G:GG | donor_gain | 0.9400 |
| 4:165039544:A:AG | donor_gain | 0.9400 |
| 4:165040068:GC:G | acceptor_gain | 0.9400 |
| 4:165040068:GCT:G | acceptor_gain | 0.9400 |
| 4:165032111:AG:A | donor_gain | 0.9200 |
| 4:165032112:GG:G | donor_gain | 0.9200 |
| 4:165032109:CCAG:C | donor_gain | 0.9100 |
| 4:165032108:TCCAG:T | donor_gain | 0.8800 |
| 4:165032110:CAG:C | donor_gain | 0.8700 |
| 4:165039230:G:GT | donor_gain | 0.8700 |
| 4:165039194:ATTGC:A | acceptor_loss | 0.8600 |
| 4:165039195:TTGCA:T | acceptor_loss | 0.8600 |
| 4:165039196:TGCA:T | acceptor_loss | 0.8600 |
| 4:165039197:GCAGG:G | acceptor_loss | 0.8600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS10000216 (4:165033713 T>C), RS1000027239 (4:165031517 G>A,C), RS1000042211 (4:165031441 T>C), RS1000133098 (4:165032025 G>A,C), RS1000782303 (4:165035972 C>T), RS1000905941 (4:165032795 C>T), RS10009883 (4:165032847 A>C), RS1001013765 (4:165030338 G>C), RS1001359861 (4:165032583 C>A,G), RS1001393410 (4:165038492 C>G), RS1001746043 (4:165038786 A>G), RS1002140510 (4:165034826 C>A), RS1002184014 (4:165039451 C>A,T), RS1002308780 (4:165034266 C>A), RS1002340279 (4:165039833 G>A)
Disease associations
OMIM: gene MIM:619416 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007830_1 | Anti-thyroid peroxidase (TPOAb) levels in Hashimoto’s thyroiditis | 5.000000e-07 |
| GCST007851_1 | Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto’s thyroiditis | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| terbufos | increases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.